Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1402
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.48%
Monthly Change
+10.77%
6 month change
+1.35%
Year Change
+1.35%
Previous Close
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
Volume
97
Markets
US Stock Market
Healthcare
SUPN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Supernus earnings missed by $0.48, revenue topped estimates
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)
Supernus Pharmaceuticals amends merger agreement to adjust milestone payments
Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock